{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:11:48Z","timestamp":1790712708147,"version":"4.1.0"},"reference-count":43,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Non-Hodgkin lymphoma (NHL) consists of a heterogeneous group of tumors. Population-based data on the familial risk for specific histopathologic subtypes have not been established. Such data are useful for clinical counseling and for searching tumor subtypes sharing common genetic pathways. We used the Swedish Family-Cancer Database to calculate standardized incidence ratios (SIRs) for histopathology-specific subtypes of NHL in 4455 offspring with NHL whose parents or siblings were affected with different types of lymphoproliferative malignancies. A familial history of NHL significantly increased the risk for NHL (SIRparent = 1.8; SIRsibling = 1.9) and for diffuse large B-cell lymphoma (SIRparent = 2.3), follicular lymphoma (SIRsibling = 2.3), and B-cell lymphoma not otherwise specified (NOS) (SIRsibling = 3.4). For a parental history of histopathology-specific concordant cancer, the risks were significantly increased for diffuse large B-cell lymphoma (SIR = 11.8), follicular NHL (SIR = 6.1), plasma cell myeloma (SIR = 2.5), and chronic lymphocytic leukemia (SIR = 5.9). Familial clusters for NHL seemed stronger in females and in siblings. Our study provides the first quantification of the familial risks for NHL by histopathology. The present findings give evidence for a strong familial association of NHL, with little differences in the magnitude of risks for various histopathologic subtypes. The patterns of risks in parents and siblings support the hypothesis of an autosomal-dominant component for diffuse large B-cell NHL and a recessive one for follicular NHL. (Blood. 2005;106:668-672)<\/jats:p>","DOI":"10.1182\/blood-2005-01-0140","type":"journal-article","created":{"date-parts":[[2005,4,6]],"date-time":"2005-04-06T09:33:45Z","timestamp":1112780025000},"page":"668-672","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":80,"title":["Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database"],"prefix":"10.1182","volume":"106","author":[{"given":"Andrea","family":"Altieri","sequence":"first","affiliation":[{"name":"From the Division of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg, Germany; and the Department of Biosciences at Novum, Karolinska Institute, Huddinge, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justo Lorenzo","family":"Bermejo","sequence":"additional","affiliation":[{"name":"From the Division of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg, Germany; and the Department of Biosciences at Novum, Karolinska Institute, Huddinge, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Hemminki","sequence":"additional","affiliation":[{"name":"From the Division of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg, Germany; and the Department of Biosciences at Novum, Karolinska Institute, Huddinge, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021223173393900_REF1","doi-asserted-by":"crossref","unstructured":"Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science.1985;228: 1440-1443.","DOI":"10.1126\/science.3874430"},{"key":"2020021223173393900_REF2","doi-asserted-by":"crossref","unstructured":"Tilly H, Rossi A, Stamatoullas A, et al. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood.1994;84: 1043-1049.","DOI":"10.1182\/blood.V84.4.1043.1043"},{"key":"2020021223173393900_REF3","doi-asserted-by":"crossref","unstructured":"International Lymphoma Study Group (ILSG). A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma: the Non-Hodgkin's Lymphoma Classification Project. Blood.1997;89: 3909-3918.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"2020021223173393900_REF4","doi-asserted-by":"crossref","unstructured":"Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature.2000;403: 503-511.","DOI":"10.1038\/35000501"},{"key":"2020021223173393900_REF5","doi-asserted-by":"crossref","unstructured":"Groves FD, Linet MS, Travis LB, Devesa SS. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histopathologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst.2000;92: 1240-1251.","DOI":"10.1093\/jnci\/92.15.1240"},{"key":"2020021223173393900_REF6","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW. In: Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues: WHO Classification of Tumors. Lyon, France: International Agency for Research on Cancer; 2001."},{"key":"2020021223173393900_REF7","doi-asserted-by":"crossref","unstructured":"Cartwright R, Brincker H, Carli PM, et al. The rise in incidence of lymphomas in Europe 1985-1992. Eur J Cancer.1999;35: 627-633.","DOI":"10.1016\/S0959-8049(98)00401-8"},{"key":"2020021223173393900_REF8","doi-asserted-by":"crossref","unstructured":"Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from non-Hodgkin's lymphomas. Leuk Res.2002;26: 903-908.","DOI":"10.1016\/S0145-2126(02)00031-0"},{"key":"2020021223173393900_REF9","unstructured":"Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2000. Bethesda, MD: National Cancer Institute; 2003."},{"key":"2020021223173393900_REF10","doi-asserted-by":"crossref","unstructured":"Steliarova-Foucher E, Stiller C, Kaatsch P, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet.2004;364: 2097-2105.","DOI":"10.1016\/S0140-6736(04)17550-8"},{"key":"2020021223173393900_REF11","doi-asserted-by":"crossref","unstructured":"Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations: Non-Hodgkin's Lymphoma Classification Project. Ann Oncol.1998;9: 717-720.","DOI":"10.1023\/A:1008265532487"},{"key":"2020021223173393900_REF12","doi-asserted-by":"crossref","unstructured":"Chiu BC, Weisenburger DD. An update of the epidemiology of non-Hodgkin's lymphoma. Clin Lymphoma.2003;4: 161-168.","DOI":"10.3816\/CLM.2003.n.025"},{"key":"2020021223173393900_REF13","doi-asserted-by":"crossref","unstructured":"Hennessy BT, Hanrahan EO, Daly PA. Non-Hodgkin lymphoma: an update. Lancet Oncol.2004;5: 341-353.","DOI":"10.1016\/S1470-2045(04)01490-1"},{"key":"2020021223173393900_REF14","unstructured":"Pisani P, Parkin DM, Munoz N, Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev.1997;6: 387-400."},{"key":"2020021223173393900_REF15","doi-asserted-by":"crossref","unstructured":"Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer.2004;4: 757-768.","DOI":"10.1038\/nrc1452"},{"key":"2020021223173393900_REF16","doi-asserted-by":"crossref","unstructured":"Beral V, Peterman T, Berkelman R, Jaffe H. AIDS-associated non-Hodgkin lymphoma. Lancet.1991;337: 805-809.","DOI":"10.1016\/0140-6736(91)92513-2"},{"key":"2020021223173393900_REF17","doi-asserted-by":"crossref","unstructured":"Rabkin CS, Biggar RJ, Horm JW. Increasing incidence of cancers associated with the human immunodeficiency virus epidemic. Int J Cancer.1991;47: 692-696.","DOI":"10.1002\/ijc.2910470511"},{"key":"2020021223173393900_REF18","doi-asserted-by":"crossref","unstructured":"Cleghorn FR, Manns A, Falk R, et al. Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidence. J Natl Cancer Inst.1995;87: 1009-1014.","DOI":"10.1093\/jnci\/87.13.1009"},{"key":"2020021223173393900_REF19","doi-asserted-by":"crossref","unstructured":"Zahm SH, Weisenburger DD, Babbitt PA, et al. A case-control study of non-Hodgkin's lymphoma and the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) in eastern Nebraska. Epidemiology.1990;1: 349-356.","DOI":"10.1097\/00001648-199009000-00004"},{"key":"2020021223173393900_REF20","unstructured":"Cantor KP, Blair A, Everett G, et al. Pesticides and other agricultural risk factors for non-Hodgkin's lymphoma among men in Iowa and Minnesota. Cancer Res.1992;52: 2447-2455."},{"key":"2020021223173393900_REF21","doi-asserted-by":"crossref","unstructured":"Nanni O, Amadori D, Lugaresi C, et al. Chronic lymphocytic leukaemias and non-Hodgkin's lymphomas by histological type in farming-animal breeding workers: a population case-control study based on a priori exposure matrices. Occup Environ Med.1996;53: 652-657.","DOI":"10.1136\/oem.53.10.652"},{"key":"2020021223173393900_REF22","doi-asserted-by":"crossref","unstructured":"Pottern LM, Linet M, Blair A, et al. Familial cancers associated with subtypes of leukemia and non-Hodgkin's lymphoma. Leuk Res.1991;15: 305-314.","DOI":"10.1016\/0145-2126(91)90005-E"},{"key":"2020021223173393900_REF23","unstructured":"Linet MS, Pottern LM. Familial aggregation of hematopoietic malignancies and risk of non-Hodgkin's lymphoma. Cancer Res.1992;52: 5468s-5473s."},{"key":"2020021223173393900_REF24","doi-asserted-by":"crossref","unstructured":"Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst.1994;86: 1600-1608.","DOI":"10.1093\/jnci\/86.21.1600"},{"key":"2020021223173393900_REF25","doi-asserted-by":"crossref","unstructured":"Zhu K, Levine RS, Gu Y, et al. Non-Hodgkin's lymphoma and family history of malignant tumors in a case-control study (United States). Cancer Causes Control.1998;9: 77-82.","DOI":"10.1023\/A:1008853421083"},{"key":"2020021223173393900_REF26","doi-asserted-by":"crossref","unstructured":"Paltiel O, Schmit T, Adler B, et al. The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: results and limitations of a registry-linked study. Cancer.2000;88: 2357-2366.","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2357::AID-CNCR21>3.0.CO;2-3"},{"key":"2020021223173393900_REF27","doi-asserted-by":"crossref","unstructured":"Chatterjee N, Hartge P, Cerhan JR, et al. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev.2004;13: 1415-1421.","DOI":"10.1158\/1055-9965.1415.13.9"},{"key":"2020021223173393900_REF28","doi-asserted-by":"crossref","unstructured":"Goldin LR, Pfeiffer RM, Gridley G, et al. Familial aggregation of Hodgkin lymphoma and related tumors. Cancer.2004;100: 1902-1908.","DOI":"10.1002\/cncr.20189"},{"key":"2020021223173393900_REF29","doi-asserted-by":"crossref","unstructured":"Goldin LR, Pfeiffer RM, Li X, Hemminki K. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood.2004;104: 1850-1854.","DOI":"10.1182\/blood-2004-01-0341"},{"key":"2020021223173393900_REF30","doi-asserted-by":"crossref","unstructured":"Chiu BC, Weisenburger DD, Zahm SH, et al. Agricultural pesticide use, familial cancer, and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev.2004;13: 525-531.","DOI":"10.1158\/1055-9965.525.13.4"},{"key":"2020021223173393900_REF31","doi-asserted-by":"crossref","unstructured":"Hemminki K, Li X, Plna K, Granstrom C, Vaittinen P. The nation-wide Swedish Family-Cancer Database\u2014updated structure and familial rates. Acta Oncol.2001;40: 772-777.","DOI":"10.1080\/02841860152619214"},{"key":"2020021223173393900_REF32","unstructured":"Hemminki K. Genetic epidemiology\u2014science and ethics on familial cancers. Acta Oncol.2001;40: 439-444."},{"key":"2020021223173393900_REF33","unstructured":"National Board of Health and Welfare. Cancer incidence in Sweden, 2000. Stockholm, Sweden: Centre for Epidemiology, National Board of Health and Welfare; 2002."},{"key":"2020021223173393900_REF34","unstructured":"SNOMED\u00ae International. The Systematized Nomenclature of Medicine. http:\/\/www.snomed.org. Accessed March 31, 2005."},{"key":"2020021223173393900_REF35","unstructured":"Esteve J, Benhamou E, Raymond L. Statistical Methods in Cancer Research. Vol IV. Descriptive Epidemiology. Lyon, France: IARC Science Publishers;1994;128: 1-302."},{"key":"2020021223173393900_REF36","doi-asserted-by":"crossref","unstructured":"Lynch HT, Marcus JN, Lynch JF. Genetics of Hodgkin's and non-Hodgkin's lymphoma: a review. Cancer Invest.1992;10: 247-256.","DOI":"10.3109\/07357909209032768"},{"key":"2020021223173393900_REF37","doi-asserted-by":"crossref","unstructured":"Hemminki K, Vaittinen P, Dong C, Easton D. Sibling risks in cancer: clues to recessive or X-linked genes? Br J Cancer.2001;84: 388-391.","DOI":"10.1054\/bjoc.2000.1585"},{"key":"2020021223173393900_REF38","doi-asserted-by":"crossref","unstructured":"Hemminki K, Li X. Familial risks of cancer as a guide to gene identification and mode of inheritance. Int J Cancer.2004;110: 291-294.","DOI":"10.1002\/ijc.20107"},{"key":"2020021223173393900_REF39","doi-asserted-by":"crossref","unstructured":"Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer\u2014analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med.2000;343: 78-85.","DOI":"10.1056\/NEJM200007133430201"},{"key":"2020021223173393900_REF40","doi-asserted-by":"crossref","unstructured":"Zhu K, Levine RS, Brann EA, et al. Risk factors for non-Hodgkin's lymphoma according to family history of haematolymphoproliferative malignancies. Int J Epidemiol.2001;30: 818-824.","DOI":"10.1093\/ije\/30.4.818"},{"key":"2020021223173393900_REF41","unstructured":"Dick F, VanLier S, Banks P, et al. Use of the working formulation for non-Hodgkin's lymphoma in epidemiologic studies: agreement between reported diagnoses and a panel of experienced pathologists. J Natl Cancer Inst.1987;78: 1137-1144."},{"key":"2020021223173393900_REF42","doi-asserted-by":"crossref","unstructured":"Martinsson U, Glimelius B, Sundstrom C. Lymphoma incidence in a Swedish county during 1969-1987. Acta Oncol.1992;31: 275-282.","DOI":"10.3109\/02841869209108173"},{"key":"2020021223173393900_REF43","doi-asserted-by":"crossref","unstructured":"Clarke CA, Glaser SL, Dorfman RF, Bracci PM, Eberle E, Holly EA. Expert review of non-Hodgkin's lymphomas in a population-based cancer registry: reliability of diagnosis and subtype classifications. Cancer Epidemiol Biomarkers Prev.2004;13: 138-143.","DOI":"10.1158\/1055-9965.EPI-03-0250"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/2\/668\/1711178\/zh801405000668.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/2\/668\/1711178\/zh801405000668.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T17:04:26Z","timestamp":1683047066000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/2\/668\/21297\/Familial-risk-for-nonHodgkin-lymphoma-and-other"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,15]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,7,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-01-0140","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,15]]}}}